What are the best antibiotics for treating group B strep (Streptococcus agalactiae) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotics for Group B Streptococcus (GBS) Infections

Penicillin G is the first-line antibiotic for treating Group B Streptococcus infections due to its narrow spectrum and effectiveness, with ampicillin being an acceptable alternative. 1

First-Line Treatment Options

For GBS During Pregnancy/Labor

  • Penicillin G: 5 million units IV initial dose, followed by 2.5-3.0 million units IV every 4 hours until delivery 1
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery (acceptable alternative but less preferred due to broader spectrum) 1

For Non-Pregnant Adults with GBS Infections

  • Penicillin G: First-line therapy for most GBS infections 2
  • For necrotizing fasciitis caused by GBS: Penicillin plus clindamycin (600-900 mg/kg every 8 hours IV) 2

Alternatives for Penicillin-Allergic Patients

Mild Penicillin Allergy (no anaphylaxis history)

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 1

Severe Penicillin Allergy (history of anaphylaxis)

  • Clindamycin: 600-900 mg IV every 8 hours (if isolate is susceptible) 2, 1
  • Vancomycin: 15-20 mg/kg IV every 8-12 hours (for resistant strains or when susceptibility unknown) 2, 3

Special Clinical Scenarios

GBS Bacteremia

  1. Remove infected catheters if present 1
  2. Obtain follow-up blood cultures to document clearance 1
  3. Consider combination therapy with gentamicin for severe infections, as this accelerates bacterial killing 4

GBS Skin and Soft Tissue Infections

  • For mixed infections including GBS: Combination therapy may be needed
  • Options include:
    • Ampicillin-sulbactam plus clindamycin plus ciprofloxacin 2
    • Imipenem/cilastatin, meropenem, or ertapenem as single agents 2

Important Considerations

Antibiotic Resistance Patterns

  • GBS remains universally susceptible to penicillins and vancomycin 5, 6
  • Resistance rates to other antibiotics:
    • Erythromycin: 21-31% resistance 5, 6
    • Clindamycin: 4-19% resistance 5, 6
    • Cephalosporins: Generally low resistance rates 5

Treatment Duration

  • For invasive infections: Continue antibiotics until clinical improvement is evident and patient has been afebrile for 48-72 hours 2
  • For GBS bacteremia: Treat until blood cultures are negative and source control is achieved 1

Pitfalls to Avoid

  1. Do not use oral antibiotics for GBS colonization during pregnancy - they are ineffective in eliminating carriage or preventing neonatal disease 2
  2. Do not rely solely on intramuscular penicillin for GBS eradication - studies show it's insufficient as sole therapy 7
  3. Do not automatically discontinue aminoglycosides when GBS infection is confirmed - combination therapy may provide more rapid killing 4
  4. Always check antibiotic susceptibility for non-penicillin options - resistance to clindamycin and erythromycin is significant 5, 6

By following these evidence-based recommendations, clinicians can optimize treatment outcomes for patients with GBS infections while minimizing the risk of antibiotic resistance.

References

Guideline

Group B Streptococcus Prevention in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic-killing kinetics of group B streptococci.

The Journal of pediatrics, 1976

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Research

Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.